VYCO · XBRL financial data

Vycor Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (VYCO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue from contracts with customers	309	308*	337	406	391	455*	436	496	514	417*	459	418
Cost of goods and services sold	32	42*	37	35	37	58*	78	81	62	82*	83	74
Gross profit	276	266*	300	371	354	397*	359	415	452	335*	375	344
Research and development	7	2*	—	2	6	7*	6	4	0*	0*	—	—
Selling, general and administrative	280	314*	295	338	368	357*	351	345	405	357*	315	323
Total operating expenses	302	330*	309	355	389	378*	371	364	420	372*	329	338
Operating income (loss)	(25)	(64)*	(10)	16	(35)	19*	(13)	51	32	(37)*	46	7
Net income (loss)	(52)	(93)*	(31)	(10)	(60)	(7)*	(39)	24	5	(63)*	20	(22)
Earnings per share, basic USD per share	(0.01)	0.00*	(0.01)	0.00	(0.01)	0.00*	(0.01)	0.00	0.00	0.00*	0.00	0.00
Earnings per share, diluted USD per share	(0.01)	0.00*	(0.01)	0.00	(0.01)	0.00*	(0.01)	0.00	0.00	0.00*	0.00	0.00
Weighted average shares, basic thousands of shares	32,629	32,629*	32,629	32,629	32,903	33,373*	33,373	33,373	33,373	33,373*	33,373	33,373
Weighted average shares, diluted thousands of shares	32,629	27,844*	32,629	32,629	32,903	33,373*	33,373	38,668	33,373	28,135*	33,373	33,373

Fiscal quarters (VYCO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	69	57	44	119	158	106	61	100	64	87	174	159
Accounts receivable	255	215	244	253	239	245	229	203	326	219	194	202
Inventory	205	234	222	218	188	222	176	156	167	159	182	191
Prepaid and other current assets	96	77	77	52	159	122	133	96	103	97	101	84
Total current assets	626	584	588	643	743	696	601	554	663	563	651	636
Property and equipment, net	262	252	236	220	210	193	177	164	148	134	116	101
Right-of-use asset	161	150	138	127	115	104	92	80	68	55	43	30
Total assets	1,054	992	969	997	1,075	998	941	879	941	830	854	813
Accounts payable	114	118	148	155	151	148	165	110	93	85	90	112
Accrued liabilities	—	—	—	—	—	158	—	—	127	90	91	94
Total current liabilities	4,031	4,074	4,256	4,307	4,553	4,497	4,654	4,582	4,815	4,781	4,948	4,930
Lease liability, non-current	112	100	89	77	65	52	40	27	14	—	—	—
Total liabilities	4,287	4,318	4,487	4,525	4,758	4,688	4,832	4,746	4,965	4,917	5,083	5,064
Accumulated deficit	(32,727)	(32,820)	(33,013)	(33,023)	(33,245)	(33,252)	(33,453)	(33,429)	(33,586)	(33,649)	(33,791)	(33,813)
Total stockholders' equity	(3,232)	(3,325)	(3,518)	(3,528)	(3,683)	(3,690)	(3,891)	(3,867)	(4,024)	(4,087)	(4,229)	(4,251)
Total liabilities and equity	1,054	992	969	997	1,075	998	941	879	941	830	854	813
Common shares outstanding (cover page) thousands of shares	32,629	32,629	32,629	32,629	33,373	33,373	33,373	33,373	33,373	33,373	33,373	33,373

Fiscal quarters (VYCO's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(52)	(93)*	(31)	(10)	(60)	(7)*	(39)	24	5	(63)*	20	(22)
Stock-based compensation	2*	2*	2	0*	6*	18*	18	18*	12*	0*	—	—
Net cash from operating activities	(13)*	6*	2	86*	10*	(38)*	(27)	47*	(72)*	39*	99	(5)*
Purchases of property and equipment	—	6*	—	—	—	(0)*	—	—	0*	2*	—	—
Net cash from investing activities	(4)*	(6)*	1	0*	(5)*	0*	—	—	0*	(2)*	2	0*
Net cash from financing activities	33*	(11)*	(16)	(11)*	33*	(14)*	(18)	(5)*	37*	(15)*	(15)	(10)*
Net change in cash	16*	(12)*	(13)	75*	38*	(52)*	(45)	39*	(35)*	23*	87	(15)*

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Vycor Medical	159	418	(4.8)*	33.4M	32.8 quarters	Q2 FY26 10-QJun 30, 2026
NutriBand	3,422	438	(585)*	12.2M	—	Q2 FY27 10-QJul 31, 2026
QHSLab	317	847	(7.8)*	15.0M	40.6 quarters	Q2 FY26 10-QJun 30, 2026
Premier Air Charter Holdings	157	5,784	318*	280.8M	—	Q2 FY26 10-QJun 30, 2026
INVO Fertility	3,733	2,175	(1,101)*	2.5M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Profusa	719	not reported	(2,632)*	605,647	0.3 quarters	Q2 FY26 10-QJun 30, 2026
LogicMark	3,496	3,349	83*	899,759	—	Q2 FY26 10-QJun 30, 2026
Stimcell Energetics	6.9	not reported	(109)	21.1M	0.1 quarters	Q1 FY27 10-QAug 31, 2026
Bluejay Diagnostics	9,599	not reported	(1,499)*	4.5M	6.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.